Thanks, John. As a reminder, in addition to using GAAP results when evaluating PDF's business, we believe it is also useful to consider our results using other non-GAAP measures. For internal purposes, the company focuses on non-GAAP net income and EBITDAR. Non-GAAP net income excludes stock-based compensation expenses, amortizations of expenses related to acquired technology and other intangible assets, restructuring charges and their related tax effects as applicable. Additionally, the income tax provision has been adjusted in our net -- non-GAAP net income to reflect cash tax expenses only. EBITDAR is equal to earnings before income tax adjusted to exclude depreciation, amortization, restructuring and stock-based compensation. You can access the earnings press release that contains a reconciliation of EBITDAR and non-GAAP net income to GAAP results in the Investors section of our website located at pdf.com. Now, let's turn to a review of the financial results. Total revenues for the quarter were $25.5 million with an GAAP net income of $4.8 million. This resulted in GAAP EPS of $0.15 per fully diluted share. Net income on a non-GAAP basis totaled $8.6 million or $0.27 per fully diluted share. Total cash increased by $8.5 million during the quarter. For the quarter, cost of sales and operating expenses, taken together, were $17.7 million on a GAAP basis and $15.8 million on a non-GAAP basis, which is an increase in non-GAAP spending of approximately $170,000 over Q2. Overall, we are very pleased with the continuing strength in the total revenues, earnings and cash for the quarter. Moving on to revenue details. Total revenues of $25.5 million for the third quarter were up approximately $700,000 as compared to $24.8 million in the prior quarter. Total revenues were comprised of design-to-silicon-yield solutions or solutions revenue of $17 million and gainshare performance incentive or gainshare revenue of $8.5 million. Our top 10 customers represented 92% of total revenues in the current quarter, slightly higher than Q2. Three of these customers contributed revenues greater than 10% each for a total of 75% as compared to 73% in prior quarter. On a geographic basis, Asia accounted for 46% of total revenues, up 15% from the prior quarter. North America accounted for 30% of total revenues, which is down 14% from the prior quarter. And Europe accounted for the remaining 24% of total revenues, down 1% from the prior quarter. Looking at solutions revenue in more detail. 13 engagements with a total of 9 different customers each contributed at least $150,000 of solutions revenue. Overall, solutions revenue at $17 million was an increase of $2 million over the prior quarter. This increase was driven primarily by the closing of the contract for our new 14-nanometer R&D engagement that John mentioned. Gainshare revenue, as stated earlier, was $8.5 million, a decrease of about $1.4 million compared to Q2. As John mentioned, the majority of this decline was due to lower volumes at one major factory client. In this case, Q3 gainshare revenues are reflective of their Q2 sales volumes and related Q1 and Q2 production volumes. The total number of customers contributing to gainshare revenue in the quarter was 9, the same as the prior -- previous quarter. Looking at expenses. Cost of sales for the quarter was $10.5 million on a GAAP basis, which was $755,000 higher than prior quarter. This increase was driven primarily by previously deferred project costs on the new 14-nanometer R&D engagement, all of which were recognized this quarter. GAAP gross margin was 59% compared to 61% in the prior quarter, reflective of the mix shift between solutions revenues and gainshare revenues in the current quarter. Our total GAAP operating expenses were $7.2 million or approximately 28% of total revenues compared to $7.6 million or 31% of total revenues in the prior quarter. R&D expenses totaled $3.4 million compared to $3.2 million in the prior quarter. R&D expense, as a percent of revenue, was 13% for both Q2 and Q3. SG&A expenses totaled $3.8 million or 15% of total revenues compared to $4.4 million or 18% of total revenues in the prior quarter. This decrease was primarily related to timing-based increases in audit and tax service fees being more than offset by compensation expense reduction. On a non-GAAP basis, looking at operating expenses and cost of sales together, total spending was $15.8 million versus $15.6 million in the prior quarter. Non-GAAP total expenses were higher compared to Q2 due to the previously mentioned deferred project costs recognition, offset by lower compensation expenses. Other income and expense was an expense of $283,000 compared to an expense of $76,000 in the previous quarter as a result of euro-based foreign exchange losses. The GAAP income tax provision for the quarter was $2.6 million, which reflects an estimated tax provision rate of 35.4%. Of this $2.6 million, approximately $800,000 represented cash tax liabilities. This represents an effective tax rate for the quarter of 10.8%. Our cash tax liability decreased from the prior quarter by approximately $570,000, primarily related to favorable changes in our state of fulfillment and deductions related to employee stock compensation. For the remainder of the year, we expect our cash tax rate to be in the range of 15% to 17% of pretax net income and the GAAP tax rate to be in the 37% to 38% range. Quarterly GAAP net income of $4.8 million resulted in EPS of $0.15 per fully diluted share, which was equivalent to the prior quarter. For the quarter, non-GAAP net income was $8.6 million compared to $7.7 million in Q2. On a non-GAAP basis, earnings per share was $0.27 per fully diluted share, an increase of $0.02 per share over the prior quarter. EBITDAR, which I defined earlier and is also defined in our press release, was $9.8 million compared to $9.4 million for the prior quarter. EBITDAR per fully diluted share was $0.31 per share compared to $0.30 in the prior quarter. Total cash at the end of the quarter was $85.2 million, an increase of $8.5 million, compared to June 30. This increase was driven by strong accounts receivables collection and proceeds from stock option exercises, partially offset by purchases of fixed assets primarily related to our proprietary testers. Cash from operations was $6.6 million. Trade account receivables days sales outstanding was 74 days for the quarter, a 3-day improvement as compared to the previous quarter. This improvement in DSO was facilitated by strong collections executed within the quarter. Unbilled accounts receivable for the quarter was $7.5 million, an increase of $1.9 million over the prior quarter and was primarily due to the percentage of completion revenues recognized on our new 14-nanometer R&D engagement. Total DSO for the quarter, including unbilled receivables, was 101 days compared to 98 days in the prior quarter, an increase of 3 days. And once again, this was primarily related to the billings -- timing of billing under the 14-nanometer R&D engagement. Headcount at the end of Q3 was 369 people worldwide compared to 357 at the end of Q2. This growth was primarily related to increases in our cost of sales organizations in China and Taiwan and our R&D organization in Germany. As with last quarter and last year, the overall financial results for the quarter reflect continued strength in our core business and our ongoing attention to spending levels. As part of our attention to spending levels, we have restructured our discretionary variable compensation plan such that expense related to these plans is directly tied to the company performance in any given period. Management practices such as this compensation policy allow the company to continually -- continue to effectively manage its spending while growing revenues, providing increased income leverage and a stronger balance sheet position. This concludes the review of the financial results for the quarter. Now, I will turn the call over to the operator for Q&A. Operator?